⌘K

Home/Filings/4/0001209191-17-039840

4//SEC Filing

ZIOPHARM ONCOLOGY INC 4

Accession 0001209191-17-039840

$TCRTCIK 0001107421operating

View on SEC.gov Company Profile

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:32 PM ET

Size

8.6 KB

Accession

0001209191-17-039840

Insider Transaction Report

Form 4

Period: 2017-06-12

ZIOPHARM ONCOLOGY INCZIOP

Director

Transactions

Exercise/Conversion
Common Stock
2017-06-12$4.85/sh+15,000$72,750→ 68,114 total
Tax Payment
Common Stock
2017-06-12$5.47/sh−13,300$72,751→ 54,814 total
Exercise/Conversion
Stock Option (Right to Buy)
2017-06-12−15,000→ 0 total
Exercise: $4.85Exp: 2017-06-18→ Common Stock (15,000 underlying)

Footnotes (2)

[F1]Represents shares withheld to pay exercise price.
[F2]5,000 shares vested and became exercisable on each of 6/18/08, 6/18/09 and 6/18/10.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001107421

Filing Metadata

Form type: 4
Filed: Jun 13, 8:00 PM ET
Accepted: Jun 14, 4:32 PM ET
Size: 8.6 KB

View on SEC.gov